Information  X 
Enter a valid email address

BATM Advanced Comm (BVC)

  Print      Mail a friend

Wednesday 08 August, 2018

BATM Advanced Comm

Agreement with Cellcom to sell IBC holdings

RNS Number : 1745X
BATM Advanced Communications Ld
08 August 2018
 

LEI: 213800FLQUB9J289RU66

 

8 August 2018

 

BATM Advanced Communications Limited

("BATM" or "the Group")

 

Agreement with Cellcom to sell IBC holdings

BATM to receive approx. $3.2m for its stake in fibre-optic consortium

 

BATM Advanced Communications Limited (LSE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces that Cellcom Israel Ltd ("Cellcom"), a leading telecommunications group, has entered a memorandum of understanding (the "Agreement") with the members of the consortium that was established in 2013 for the construction of a new fibre optic network in Israel alongside the Israel Electric Corporation ("IBC"), as previously announced, to acquire the consortium's stake in IBC. BATM will receive NIS12m (c. $3.2m) for its 7.5% interest in IBC.

 

The Agreement is subject to the receipt of regulatory approval, which is expected to occur by the end of the first half of 2019. The Group will receive the proceeds from the sale upon the closing of the transaction.

 

Dr Zvi Marom, Chief Executive Officer of BATM, said: "We are pleased to have entered into this agreement with Cellcom, along with our consortium partners, which will generate additional value from this legacy asset. We look forward to seeing Cellcom and the Israel Electric Corporation progress the project and wish them all the best for the future."  

 

 

 

Enquiries:

 

BATM Advanced Communications


Dr Zvi Marom, Chief Executive Officer

+972 9866 2525                 

Moti Nagar, Chief Financial Officer






Shore Capital


Mark Percy, Anita Ghanekar

+44 20 7408 4050 





Luther Pendragon


Harry Chathli, Claire Norbury

+44 20 7618 9100

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
AGRFKFDBOBKKKFK

a d v e r t i s e m e n t